YY2 and neoplasm: Overall, these results indicate that mutations in the YY2 zinc‐finger domains as found in clinical tumor patients abrogated the YY2/SLC7A11 axis, and consequently, abrogated the effect of YY2 on tumor cell ferroptosis.